I think it interesting that one of the directors increased his interest through a private company about September 2018. I think the purchases were about $400,000. He must have some confidence. Technogas has only been used on a limited type of procedure, lung function. From my understanding, ther is now also a market for diagnosis in relation to pulmonary embolism which is quite a separate area. If the approvals come through, the longer terms sales prospects are enhanced. It seems as if the US FDA approval process is a likely catalyst for increasing sales.
I think it interesting that one of the directors increased his...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.025(2.45%) |
Mkt cap ! $110.5M | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.03 | 99.0¢ | $207.2K | 207.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9989 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |